Select Medical Holdings Corporation (SEM)
NYSE: SEM · Real-Time Price · USD
19.06
+0.80 (4.38%)
Dec 20, 2024, 4:02 PM EST - Market closed
Select Medical Holdings Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for SEM stock have an average target of 44.5, with a low estimate of 42 and a high estimate of 47. The average target predicts an increase of 133.47% from the current stock price of 19.06.
Analyst Consensus: Buy
* Price targets were last updated on Nov 4, 2024.
Analyst Ratings
The average analyst rating for SEM stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 1 | 1 | 1 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 25, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $40 → $47 | Buy | Maintains | $40 → $47 | +146.59% | Nov 4, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +151.84% | Nov 4, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +151.84% | Nov 1, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +151.84% | Sep 6, 2024 |
Financial Forecast
Revenue This Year
6.64B
from 6.66B
Decreased by -0.30%
Revenue Next Year
6.23B
from 6.64B
Decreased by -6.17%
EPS This Year
2.05
from 1.91
Increased by 7.53%
EPS Next Year
1.63
from 2.05
Decreased by -20.30%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 7.4B | 7.8B | 8.2B |
| Avg | 6.6B | 6.2B | 7.2B |
| Low | 5.1B | 5.2B | 5.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 11.1% | 16.9% | 31.9% |
| Avg | -0.3% | -6.2% | 14.9% |
| Low | -24.0% | -21.4% | -11.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2.19 | 2.71 | 3.13 |
| Avg | 2.05 | 1.63 | 2.24 |
| Low | 1.93 | 1.12 | 1.45 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 15.1% | 32.1% | 91.5% |
| Avg | 7.5% | -20.3% | 37.0% |
| Low | 1.3% | -45.5% | -11.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.